United States · FDA National Drug Code directory
montelukast sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68788-7669_f9ab7e9f-ce5e-4c52-919e-66602d0c719e
- Product NDC
- 68788-7669
- Form
- TABLET, CHEWABLE
- Composition / generic term
- montelukast sodium
- Labeler
- Preferred Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200228
- Source listing expiry
- 20271231
Source-listed ingredients
- MONTELUKAST — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 10 TABLET, CHEWABLE in 1 BOTTLE (68788-7669-1) · 68788-7669-1
- 20 TABLET, CHEWABLE in 1 BOTTLE (68788-7669-2) · 68788-7669-2
- 30 TABLET, CHEWABLE in 1 BOTTLE (68788-7669-3) · 68788-7669-3
- 14 TABLET, CHEWABLE in 1 BOTTLE (68788-7669-4) · 68788-7669-4
- 60 TABLET, CHEWABLE in 1 BOTTLE (68788-7669-6) · 68788-7669-6
- 90 TABLET, CHEWABLE in 1 BOTTLE (68788-7669-9) · 68788-7669-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →